Dr. Schlegelmilch, who has served at the hospital for more than 30 years, has accepted the position of director of medical affairs in rheumatology at Janssen Biotech, a division of Johnson & Johnson.
Related Articles on Hospital Executive Moves:
New Hampshire’s Huggins Hospital CEO Dave Tower to Resign
Massachusetts’ Heywood Hospital Names Winfield Brown CEO
California’s Citrus Valley Health Names Dr. Paveljit Bindra CMO, CMIO
